Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionEPG Wealth Management LLC
Latest Disclosed Ownership4,282 shares
Latest Disclosed Value $ 596,752
EPG Wealth Management LLC reports 3.80% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 7, 2026 - EPG Wealth Management LLC filed a 13F-HR form disclosing ownership of 4,282 shares of Gilead Sciences, Inc. (CH:GILD) valued at $596,752 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2026 disclosing 4,451 shares of Gilead Sciences, Inc.. This represents a change in shares of -3.80% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F GILEAD SCIENCES COM 375558103 4,282 -169 -3.80 597 9.16 0.1619
2026-01-28 2025-12-31 13F GILEAD SCIENCES COM 375558103 4,451 3 0.07 546 10.75 0.1471
2025-11-03 2025-09-30 13F GILEAD SCIENCES COM 375558103 4,448 -179 -3.87 494 -3.71 0.1360
2025-08-05 2025-06-30 13F GILEAD SCIENCES COM 375558103 4,627 89 1.96 513 0.79 0.1540
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 4,538 -105 -2.26 509 18.69 0.1416
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 4,643 28 0.61 429 10.88 0.1131
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 4,615 4,615 387 14.54 0.0976
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 0 -5,082 -100.00 338 -9.41 0.0788
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 5,082 4 0.08 372 -0.27 0.0912
2024-02-15 2023-12-31 13F GILEAD SCIENCES COM 375558103 5,078 -582 -10.28 373 -12.03 0.0982
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 5,660 -6,304 -52.69 424 -54.01 0.1279
2023-08-15 2023-06-30 13F GILEAD SCIENCES COM 375558103 11,964 184 1.56 922 -5.63 0.2728
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 11,780 11,780 977 0.3083
2020-08-06 2020-06-30 13F GILEAD SCIENCES INC COM Stock 375558103 0 -410 -100.00 0 -100.00
2020-05-05 2020-03-31 13F GILEAD SCIENCES INC COM Stock 375558103 410 267 186.71 30 233.33 0.0220
2020-02-14 2019-12-31 13F GILEAD SCIENCES INC COM Stock 375558103 143 143 9 0.0066
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.